Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 22

1.

Rapid Assessment and Visualization of Normality in High-Content and Other Cell-Level Data and Its Impact on the Interpretation of Experimental Results.

Haney SA.

J Biomol Screen. 2014 Mar 20;19(5):672-684. [Epub ahead of print]

PMID:
24652972
[PubMed - as supplied by publisher]
2.

Interview with Steven A. Haney, PhD.

Haney SA, Glaser V.

Assay Drug Dev Technol. 2014 Jan-Feb;12(1):12-5. doi: 10.1089/adt.2014.1201.pr. No abstract available.

PMID:
24547741
[PubMed - in process]
3.

siRNA off-target effects can be reduced at concentrations that match their individual potency.

Caffrey DR, Zhao J, Song Z, Schaffer ME, Haney SA, Subramanian RR, Seymour AB, Hughes JD.

PLoS One. 2011;6(7):e21503. doi: 10.1371/journal.pone.0021503. Epub 2011 Jul 5.

PMID:
21750714
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Single cell cytometry of protein function in RNAi treated cells and in native populations.

LaPan P, Zhang J, Pan J, Hill A, Haney SA.

BMC Cell Biol. 2008 Aug 1;9:43. doi: 10.1186/1471-2121-9-43.

PMID:
18673568
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Expanding the repertoire of RNA interference screens for developing new anticancer drug targets.

Haney SA.

Expert Opin Ther Targets. 2007 Nov;11(11):1429-41. Review.

PMID:
18028008
[PubMed - indexed for MEDLINE]
6.

Increasing the robustness and validity of RNAi screens.

Haney SA.

Pharmacogenomics. 2007 Aug;8(8):1037-49. Review.

PMID:
17716236
[PubMed - indexed for MEDLINE]
7.

Transcriptional changes associated with breast cancer occur as normal human mammary epithelial cells overcome senescence barriers and become immortalized.

Li Y, Pan J, Li JL, Lee JH, Tunkey C, Saraf K, Garbe JC, Whitley MZ, Jelinsky SA, Stampfer MR, Haney SA.

Mol Cancer. 2007 Jan 18;6:7.

PMID:
17233903
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

High-content screening moves to the front of the line.

Haney SA, LaPan P, Pan J, Zhang J.

Drug Discov Today. 2006 Oct;11(19-20):889-94. Epub 2006 Sep 7. Review.

PMID:
16997138
[PubMed - indexed for MEDLINE]
9.

Discovery of novel inhibitors of the ZipA/FtsZ complex by NMR fragment screening coupled with structure-based design.

Tsao DH, Sutherland AG, Jennings LD, Li Y, Rush TS 3rd, Alvarez JC, Ding W, Dushin EG, Dushin RG, Haney SA, Kenny CH, Malakian AK, Nilakantan R, Mosyak L.

Bioorg Med Chem. 2006 Dec 1;14(23):7953-61. Epub 2006 Aug 17.

PMID:
16919463
[PubMed - indexed for MEDLINE]
10.

Anticancer drug development incorporating high-content screening and RNAi: synergistic approaches to improve target identification and validation.

Haney SA.

Expert Opin Drug Discov. 2006 Jun;1(1):19-29. doi: 10.1517/17460441.1.1.19.

PMID:
23506030
[PubMed]
11.

RNAi and high-content screening in target identification and validation.

Haney SA.

IDrugs. 2005 Dec;8(12):997-1001.

PMID:
16320133
[PubMed - indexed for MEDLINE]
12.

Combinatorial synthesis of substituted 3-(2-indolyl)piperidines and 2-phenyl indoles as inhibitors of ZipA-FtsZ interaction.

Jennings LD, Foreman KW, Rush TS 3rd, Tsao DH, Mosyak L, Kincaid SL, Sukhdeo MN, Sutherland AG, Ding W, Kenny CH, Sabus CL, Liu H, Dushin EG, Moghazeh SL, Labthavikul P, Petersen PJ, Tuckman M, Haney SA, Ruzin AV.

Bioorg Med Chem. 2004 Oct 1;12(19):5115-31. Erratum in: Bioorg Med Chem. 2005 Oct 15;13(20):5884. Haney, Steven A [added].

PMID:
15351395
[PubMed - indexed for MEDLINE]
13.
14.

Genomics in anti-infective drug discovery--getting to endgame.

Haney SA, Alksne LE, Dunman PM, Murphy E, Projan SJ.

Curr Pharm Des. 2002;8(13):1099-118. Review.

PMID:
12052222
[PubMed - indexed for MEDLINE]
15.

Genetic selection in Saccharomyces of mutant mammalian adenylyl cyclases with elevated basal activities.

Haney SA, Xu J, Lee SY, Ma CL, Duzic E, Broach JR, Manfredi JP.

Mol Genet Genomics. 2001 Aug;265(6):1120-8.

PMID:
11523785
[PubMed - indexed for MEDLINE]
16.

Genetic analysis of the Escherichia coli FtsZ.ZipA interaction in the yeast two-hybrid system. Characterization of FtsZ residues essential for the interactions with ZipA and with FtsA.

Haney SA, Glasfeld E, Hale C, Keeney D, He Z, de Boer P.

J Biol Chem. 2001 Apr 13;276(15):11980-7. Epub 2001 Jan 16.

PMID:
11278571
[PubMed - indexed for MEDLINE]
Free Article
17.

CAC3(MSI1) suppression of RAS2(G19V) is independent of chromatin assembly factor I and mediated by NPR1.

Johnston SD, Enomoto S, Schneper L, McClellan MC, Twu F, Montgomery ND, Haney SA, Broach JR, Berman J.

Mol Cell Biol. 2001 Mar;21(5):1784-94.

PMID:
11238915
[PubMed - indexed for MEDLINE]
Free PMC Article
18.
19.

Lrp, a leucine-responsive protein, regulates branched-chain amino acid transport genes in Escherichia coli.

Haney SA, Platko JV, Oxender DL, Calvo JM.

J Bacteriol. 1992 Jan;174(1):108-15.

PMID:
1729203
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Amino acid transport in bacteria.

Haney SA, Oxender DL.

Int Rev Cytol. 1992;137:37-95. Review. No abstract available.

PMID:
1428673
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk